Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Brii Biosciences advances HBV study data alongside half year financial results

Biotechnology company Brii Biosciences released Phase 2b clinical data for its hepatitis B treatment strategy on 21 August 2026 alongside half year financial reporting

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Health & Medicine

More from Friday 21 August →